|
1
|
Futreal PA, Coin L, Marshall M, et al: A
census of human cancer genes. Nat Rev Cancer. 4:177–183. 2004.
View Article : Google Scholar
|
|
2
|
Pleasance ED, Cheetham RK, Stephens PJ, et
al: A comprehensive catalogue of somatic mutations from a human
cancer genome. Nature. 463:191–196. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pleasance ED, Stephens PJ, O'Meara S, et
al: A small-cell lung cancer genome with complex signatures of
tobacco exposure. Nature. 463:184–190. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Greenman C, Stephens P, Smith R, et al:
Patterns of somatic mutation in human cancer genomes. Nature.
446:153–158. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lipson D, Capelletti M, Yelensky R, et al:
Identification of new ALK and RET gene fusions from colorectal and
lung cancer biopsies. Nat Med. 18:382–384. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chiarle R, Voena C, Ambrogio C, Piva R and
Inghirami G: The anaplastic lymphoma kinase in the pathogenesis of
cancer. Nat Rev Cancer. 8:11–23. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shackelford RE, Vora M, Mayhall K and
Cotelingam J: ALK-rearrangements and testing methods in non-small
cell lung cancer: a review. Genes Cancer. 5:1–14. 2014.PubMed/NCBI
|
|
8
|
Morales La Madrid A, Campbell N, Smith S,
Cohn SL and Salgia R: Targeting ALK: a promising strategy for the
treatment of non-small cell lung cancer, non-Hodgkin's lymphoma,
and neuroblastoma. Target Oncol. 7:199–210. 2012.PubMed/NCBI
|
|
9
|
Hallberg B and Palmer RH: Mechanistic
insight into ALK receptor tyrosine kinase in human cancer biology.
Nat Rev Cancer. 13:685–700. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Morris SW, Kirstein MN, Valentine MB, et
al: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM,
in non-Hodgkin's lymphoma. Science. 263:1281–1284. 1994. View Article : Google Scholar
|
|
11
|
Soda M, Choi YL, Enomoto M, et al:
Identification of the transforming EML4-ALK fusion gene in
non-small-cell lung cancer. Nature. 448:561–566. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Scott MP, Zappacosta F, Kim EY, Annan RS
and Miller WT: Identification of novel SH3 domain ligands for the
Src family kinase Hck. Wiskott-Aldrich syndrome protein (WASP),
WASP-interacting protein (WIP), and ELMO1. J Biol Chem.
277:28238–28246. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
UniProt Consortium, . Activities at the
Universal Protein Resource (UniProt). Nucleic Acids Res.
42:(Database issue). D191–D198. 2014.PubMed/NCBI
|
|
14
|
Smith TF, Gaitatzes C, Saxena K and Neer
EJ: The WD repeat: a common architecture for diverse functions.
Trends Biochem Sci. 24:181–185. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mayer BJ and Eck MJ: SH3 domains. Minding
your p's and q's. Curr Biol. 5:364–367. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nguyen JT, Porter M, Amoui M, Miller WT,
Zuckermann RN and Lim WA: Improving SH3 domain ligand selectivity
using a non-natural scaffold. Chem Biol. 7:463–473. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bilsland JG, Wheeldon A, Mead A, et al:
Behavioral and neurochemical alterations in mice deficient in
anaplastic lymphoma kinase suggest therapeutic potential for
psychiatric indications. Neuropsychopharmacology. 33:685–700. 2008.
View Article : Google Scholar
|
|
18
|
Soda M, Takada S, Takeuchi K, et al: A
mouse model for EML4-ALK-positive lung cancer. Proc Natl Acad Sci
USA. 105:19893–19897. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cussac D, Greenland C, Roche S, et al:
Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell
lymphoma recruits, activates, and uses pp60c-src to mediate its
mitogenicity. Blood. 103:1464–1471. 2004. View Article : Google Scholar : PubMed/NCBI
|
